SCA practice case · Telephone consultation
“The letter says I’ve got kidney disease — am I going on dialysis?”
Telephone consultation
Adult patient
Straightforward
Long-term conditions & cancerInvestigations & results
The candidate brief
This is what you would read in the 3-minute window before the patient connects. Read it once, note two or three hypotheses and one thing you must not miss, then stop.
Patient
Patricia Nwosu · 64 years · female
Setting
Telephone — patient distressed by a kidney blood-test letter.
Past history
- Hypertension
- Type 2 diabetes
- CKD G3a (new code)
Medication
- Amlodipine
- Metformin
Allergies
NKDA
Recent notes
⚠ eGFR 52, stable for 12 months. ACR normal to mildly raised. Letter sent: ‘chronic kidney disease’. No discussion documented.
Reason for contact
Telephone call. “The letter says I’ve got kidney disease — am I going on dialysis?”
Practise this case
The full case is in the Hot Seat with the Gold plan. You get a 12-minute timer, a role-player script with facts released only when asked, examiner checkpoints by the three RCGP domains, a model consultation and the guidance behind it.
What this case tests
Show the learning points (spoiler: read after you have practised)
A CKD stage-3a result (eGFR ~52, stable, ACR normal/mildly raised) in a well 64-year-old is a RISK-COMMUNICATION consultation: the word "disease" in a letter, with no conversation, lands as a dialysis-and-death sentence — here amplified by a neighbour’s end-stage disease mapped onto herself. The task is to reframe ACCURATELY without minimising: CKD3a is common (age, BP, diabetes), usually stable, the large majority never need dialysis (they die with it, not of it), and at this stage it is largely a cardiovascular risk marker to act on. Lay out the protective levers (BP and diabetes control, ACE inhibitor/ARB where indicated — NICE NG203: with diabetes, if ACR is 3 mg/mmol or more — avoid NSAIDs, atorvastatin 20 mg per NICE NG238, dose review, periodic eGFR+ACR monitoring), address guilt without shaming, and know the genuine NICE NG203 referral criteria (5-year kidney failure risk over 5%, ACR 70 or more, ACR 30 or more with haematuria, a sustained significant eGFR fall, hypertension uncontrolled on 4 or more drugs, suspected rare or genetic cause) that distinguish her stable picture from those needing nephrology. Respond to the distress first, dismantle the neighbour-driven catastrophe, and safety-net (NSAID avoidance, sick-day guidance, monitoring) so she leaves reassured and engaged. eGFR 52 (CKD stage 3a) that is STABLE over a year with normal/mildly-raised ACR is common, usually age- and blood-pressure-related, and the large majority of people at this stage NEVER need dialysis and die WITH it, not OF it. The label "disease" frightens people far more than the mild, manageable reality. If reached: nobody explained the result before the letter; the term landed as a death sentence. The consultation is largely RISK COMMUNICATION — reframing a number into a manageable, mostly-stable condition without either minimising or terrifying.
The guidance behind it
Similar SCA cases
gpreasoning.uk is not affiliated with or endorsed by the RCGP. Our cases are original teaching material written for practice; none is an exam recall. For anything official about the SCA, check the RCGP SCA pages.